How should doctors counsel their patients about peptides that have not been FDA approved
Understanding patient preferences regarding surveillance attributes can help identify which strategies will be well accepted when implemented in practice
Dr Martin Juneau, M.D., FRCP Cardiologue, directeur de l'Observatoire de la prvention de l'Institut de Cardiologie de Montral
Aslam MR, Muhammad Asif H, Ahmad K, Jabbar S, Hayee A, Sagheer MS, Rehman JU, Khalid S, Hashmi AS, Rajpoot SR, Sharif A (2022) Global impact and contributing factors in varicose vein disease development
Shawn Achtman, DO Physical Medicine & Rehabilitation, Sports Medicine Romario Yousif, PA-C Physician Assistant, Co-Founder Megan Brias, RN Registered Nurse, Operations Team Nicole Choulagh, RN Registered Nurse, Operations Team GET STARTED What do I need to know about TRT